Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crest Solutions was an Ireland-based engineering and automation company serving regulated manufacturers, particularly biopharma, pharmaceuticals, medical devices, and other high-end manufacturing customers. The company provided automation, machine vision, serialization, laboratory and supply-chain process solutions, along with lifecycle and professional services to optimize operational performance rather than develop therapeutics. Crest Solutions became part of the CXV Global alliance with Xyntek and VistaLink and, in October 2022, that platform combined with Panacea Technologies under common ownership. The combined business was later renamed Catalyx, which now operates as the active successor organization. For biotech and pharma analysts, Crest Solutions is best understood as a life-science operations and manufacturing-enablement company, not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crest Solutions.